These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 25588354)
1. Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. Allen Reish HE; Standaert DG J Parkinsons Dis; 2015; 5(1):1-19. PubMed ID: 25588354 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
3. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873 [TBL] [Abstract][Full Text] [Related]
4. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. Lewis KA; Yaeger A; DeMartino GN; Thomas PJ J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295 [TBL] [Abstract][Full Text] [Related]
5. Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants. Roodveldt C; Labrador-Garrido A; Gonzalez-Rey E; Fernandez-Montesinos R; Caro M; Lachaud CC; Waudby CA; Delgado M; Dobson CM; Pozo D PLoS One; 2010 Oct; 5(10):e13481. PubMed ID: 21048992 [TBL] [Abstract][Full Text] [Related]
6. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease? Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. Mehra S; Sahay S; Maji SK Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581 [TBL] [Abstract][Full Text] [Related]
8. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Cardinale A; Calabrese V; de Iure A; Picconi B Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204581 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease. Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171 [TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease. Garcia P; Jürgens-Wemheuer W; Uriarte Huarte O; Michelucci A; Masuch A; Brioschi S; Weihofen A; Koncina E; Coowar D; Heurtaux T; Glaab E; Balling R; Sousa C; Kaoma T; Nicot N; Pfander T; Schulz-Schaeffer W; Allouche A; Fischer N; Biber K; Kleine-Borgmann F; Mittelbronn M; Ostaszewski M; Schmit KJ; Buttini M Glia; 2022 May; 70(5):935-960. PubMed ID: 35092321 [TBL] [Abstract][Full Text] [Related]
14. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. Theodore S; Cao S; McLean PJ; Standaert DG J Neuropathol Exp Neurol; 2008 Dec; 67(12):1149-58. PubMed ID: 19018246 [TBL] [Abstract][Full Text] [Related]
15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
16. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Thome AD; Standaert DG; Harms AS PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270 [TBL] [Abstract][Full Text] [Related]
17. Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease. Hatton SL; Pandey MK Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163013 [TBL] [Abstract][Full Text] [Related]
18. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation. Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease. Kasen A; Houck C; Burmeister AR; Sha Q; Brundin L; Brundin P Neurobiol Dis; 2022 May; 166():105654. PubMed ID: 35143968 [TBL] [Abstract][Full Text] [Related]
20. The Interplay between Alpha-Synuclein Clearance and Spreading. Lopes da Fonseca T; Villar-Piqué A; Outeiro TF Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]